Research and Development

Research in Apotex^® includes the development of generic, biosimilar and innovative pharmaceutical products.

The new products have been a critical component of our growth and have led to our expertise in the development of formulations, synthesis of active ingredients and chemical analysis.

We have invested more than 1 trillion Canadian dollars in the last ten years to develop innovative product solutions in several categories, with a forecast to double that investment in the next ten years. We are part of the Top 100 of Canadian companies investing in Research and Development.